المشهد
المشهد
جاهز للتشغيل
جاهز للتشغيل
A Japanese hospital successfully performed the first procedure involving the implantation of heart muscle cell chips derived from stem cells using an approved commercial treatment. The operation was carried out on a woman in her fifties with the aim of improving her heart function and enhancing her quality of life. This hour-long procedure marks the first clinical use of regenerative therapy following approval by Japanese authorities in March. It is expected to help reduce symptoms of heart failure and increase patients' physical endurance. Previously, eight patients underwent clinical trials demonstrating improvements in their symptoms and heart functions, with four of them showing notable progress.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading